🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Astellas Pharma Europe BV — Licensed Medicines

13 medicines held by Astellas Pharma Europe BV on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 13 products held by Astellas Pharma Europe BV
MedicineActive substanceLicence holderStatus
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/001-002
Tacrolimus Astellas Pharma Europe BV
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/1-2
Tacrolimus Astellas Pharma Europe BV
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/003-006
Tacrolimus Astellas Pharma Europe BV
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/3-6
Tacrolimus Astellas Pharma Europe BV
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/011-013
Tacrolimus Astellas Pharma Europe BV
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/11-13
Tacrolimus Astellas Pharma Europe BV
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/007-008
Tacrolimus Astellas Pharma Europe BV
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/7-8
Tacrolimus Astellas Pharma Europe BV
Betmiga 25 mg prolonged-release tablets
EU/1/12/809/001-007
Mirabegron (ym178) Astellas Pharma Europe BV
Betmiga 50 mg prolonged-release tablets
EU/1/12/809/008-014
Mirabegron (ym178) Astellas Pharma Europe BV
Modigraf 0.2 mg granules for oral suspension
EU/1/09/523/001
Tacrolimus Astellas Pharma Europe BV
Modigraf 1 mg granules for oral suspension
EU/1/09/523/002
Tacrolimus Astellas Pharma Europe BV
Xtandi 40 mg soft capsules
EU/1/13/846/001
Enzalutamide Astellas Pharma Europe BV
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.